Registered entities
Retrophin, Inc.
Reg. No. 1438533United States
Innovation
7 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 219 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 4 |
Social engagement
Social engagement: 44.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
4 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Private equity | 2 | 50% |
| Bank & private debt | 1 | 25% |
Hiring activity
Hires periodically
15 roles tracked across 4 of the last 12 months
31 Mar 2026 · Senior Medical Science Liaison - Northeast · Manchester
17 Mar 2026 · Senior Medical Science Liaison - Western US (Pegtibatinase) · Oklahoma City
14 Mar 2026 · Senior Manager, Pharmacometrics, Clinical Pharmacology · Denver
9 Mar 2026 · Vice President, Clinical Development (Rare Metabolic Disease) · Detroit
Based on job postings tracked across public sources.
Recent activity
18 Jun 2026
Event
American Transplant Congress 2026Boston
16 Jun 2026
Event
NephCure Patient Summit
16 Jun 2026
Leadership hire
chief research officer